Gastrooesophageal cancer+1
RecruitingA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
A study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
- Disease:Gastrooesophageal cancerOesophageal adenocarcinoma
- Substances:FRUQUINTINIBTrifluridine+1
France- Participants:18–64 years · 65+ years
- Substances:FRUQUINTINIB
- Sponsor:Fondation Franc.Cancerologie Digestive








